Straits Times Index
3,078.91 +5.92 (+0.19%) Nikkei
33,428.32 -58.57 (-0.17%) Hang Seng
17,042.88 0.00 (0.00%) FTSE 100
7,453.75 +30.29 (+0.41%) Bitcoin USD
37,665.31 -78.20 (-0.21%) CMC Crypto 200
780.57 -3.08 (-0.39%)
Inogen Inc (6IO.SG)
| Previous close | 5.35 |
| Open | 5.25 |
| Bid | 5.35 x 200000 |
| Ask | 5.40 x 200000 |
| Day's range | 5.25 - 5.25 |
| 52-week range | 3.92 - 24.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 21 Feb 2024 - 26 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireInogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO
GOLETA, Calif., November 13, 2023--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has appointed Kevin Smith as Inogen’s President and Chief Executive Officer and a member of the Board of Directors, effective immediately, succeeding Nabil Shabshab.
ZacksInogen (INGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Business WireInogen to Present at Upcoming Investor Conferences in November 2023
GOLETA, Calif., November 09, 2023--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences:
